Public SEC Form D records
Biotech Growth Form D filings - May 2026
This page lists the 5 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Growth stage in May 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 5
- Issuers
- 5
- Combined disclosed
- $1.1B
Directory links
Filing records
5 crawlable filing links in this facet.
- BioPharma Credit Investments V LPMay 28, 2026 / Reg D 506(b)Undisclosed
- BioPharma Credit Investments V (Offshore-A) LPMay 28, 2026 / Reg D 506(b)Undisclosed
- BioPharma Credit Investments V (Cayman) LPMay 28, 2026 / Reg D 506(b)Undisclosed
- OrbiMed Asia Partners VI, L.P.May 28, 2026 / Reg D 506(b) / NY$850.0M
- Cancer Focus Fund II, LPMay 22, 2026 / Reg D 506(c) / LA$250.0M